免疫系统
免疫学
炎症
受体
生物
小胶质细胞
神经免疫学
吞噬作用
髓样
免疫
病菌
传染病(医学专业)
疾病
医学
遗传学
病理
作者
Amanda de Oliveira Matos,Pedro Henrique dos Santos Dantas,Helena Auler Galvão de Barros Queiroz,Marcelle Figueira Marques da Silva,Helioswilton Sales‐Campos
标识
DOI:10.1080/1040841x.2022.2146481
摘要
The triggering receptor expressed on myeloid cells-2 (TREM-2) is an immune receptor expressed on immune and non-immune cells, more frequently investigated in neurodegenerative disorders and considered a marker for microglia activation. In infectious diseases, the receptor was initially believed to be an anti-inflammatory molecule, opposing the inflammation triggered by TREM-1. Currently, TREM-2 is associated with different aspects in response to infectious stimuli, including the induction of bacterial phagocytosis and clearance, containment of exacerbated pro-inflammatory responses, induction of M2 differentiation and activation of Th1 lymphocytes, besides of neurological damage after viral infection. Here, we present and discuss results published in the last two decades regarding the expression, activation and functions of TREM-2 during the course of bacterial, viral, fungal and parasitic infections. A surprisingly plasticity was observed regarding the roles of the receptor in the aforementioned contexts, which largely varied according to the cell/organ and pathogen type, besides influencing disease outcome. Therefore, our review aimed to critically overview the role of TREM-2 in infectious diseases, highlighting its potential to be used as a clinical biomarker or therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI